from sdb scott ballantyne subject re burzynski antineoplaston in article jschwimmer josh schwimmer write any opinion on burzynski antineoplaston or information about the current statu of hi research would be appreciate burzynski work be not too promise none of hi through antineoplaston have be show to have antineoplastic effect against experimental cancer the ncus conduct test of and against leukemium in mouse with the result that dose high enough to produce toxic effect in the mouse be not effective in inhibit the growth of the tumor or kill it these be in and burzynski claim that be the active factor common to all of and something which he ha not show ha only be extract from he also ha show that through be actually distinct substance the ncus conduct a series of test use against a standard panel of tumor that include different cell line from tumor in the follow class leukemium non-small-cell and small-cell lung cancer colon cancer cancer of the central nervou system melanoma ovarian cancer and renal cancer exhibit neither growth inhibition nor cytotoxicity at the dose level test it be necessary to proces since it be not soluble burzynski theory require soluble agent but thi basically hydrolize it to pag which he call a pag be not an information carry peptide something which byrzynski claim be necessary for antineoplastic activity a also derive from be a mixture of pa and pag pa also not a peptide can be purchase at a chemical supply house for about a gram be chemically extremely similar to glutithamide and thalidomide both of which be habit form and can cause peripheral neuropathy the nasty effect of thalidomide be widely know in spite of thi similarity do not appear to have be test for it potential to induce teratogenicity or peripheral neuropathy many of burzynski statement about the origin of hi theory early research past and present support by other for hi work have be show to be untrue sdb sdb 